Venmax Drugs and Pharmaceuticals inform about compliances-certificate
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Venmax Drugs and Pharmaceuticals has enclosed certificate issued by CIL Securities, Registrar and Share Transfer Agent (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
